Alnylam Pharmaceuticals, Inc. ALNY
159.85 USD +8.21 (+5.41%)
At closeNov 11, 2026, 7:27 PM EST
161.83 +1.98 +1.24%
After hours · Nov 11, 7:27 PM ET
151.85 Day range 159.92
149.18 52-week range 479.79
- YTD
- -59.80%
- 1 year
- -64.63%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.66B | 966.43M | 812.69M | 866.39M | 819.98M | |
| 1.66B | 966.43M | 812.69M | 866.39M | 819.98M | |
| 1.27B | 1.80B | 1.68B | 1.38B | 1.66B | |
| 1.25B | 1.73B | 1.63B | 1.33B | 1.62B | |
| 22.17M | 68.59M | 49.39M | 49.39M | 40.89M | |
| 777.57M | 405.31M | 327.79M | 237.96M | 198.57M | |
| 4.05B | 3.30B | 2.98B | 2.69B | 2.81B | |
| 708.06M | 693.93M | 725.79M | 738.63M | 733.63M | |
| 4.97B | 4.24B | 3.83B | 3.55B | 3.64B | |
| 265.59M | 154.90M | 96.50M | 82.26M | 77.63M | |
| 2.97B | 3.14B | 2.68B | 2.61B | 2.19B | |
| 1.47B | 1.19B | 967.79M | 767.91M | 695.71M | |
| 2.70B | 2.98B | 2.59B | 2.53B | 2.11B | |
| 4.18B | 4.17B | 4.05B | 3.70B | 3.06B | |
| -6.70B | -7.29B | -7.01B | -6.57B | -5.44B | |
| -20.10M | -34.52M | -23.38M | -44.65M | -33.26M | |
| 789.18M | 67.09M | -220.64M | -158.22M | 588.20M | |
| 789.18M | 67.09M | -220.64M | -158.22M | 588.20M | |
| 915.67M | 944.70M | 847.18M | 854.11M | 834.73M | |
| 2.97B | 3.14B | 2.68B | 2.61B | 2.19B | |
| 4.84M | 55.48M | 290.93M | 235.90M | 301.84M | |
| 82.72M | 78.51M | 89.15M | 128.96M | 86.36M | |
| 2.71B | 2.99B | 3.08B | 2.94B | 2.36B | |
| 115.72M | 88.42M | 55.52M | 98.09M | 73.43M | |
| 125.97M | 116.86M | 10.10M | 0 | 0 |